Tue, December 13, 2022

Samantha Semenkow Initiated (SNSE) at Strong Buy and Held Target at $6 on, Dec 13th, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. g-buy-and-held-target-at-6-on-dec-13th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Samantha Semenkow of Citigroup, Initiated "Sensei Biotherapeutics, Inc." (SNSE) at Strong Buy and Held Target at $6 on, Dec 13th, 2022.

Samantha has made no other calls on SNSE in the last 4 months.



There is 1 other peer that has a rating on SNSE. Out of the 1 peers that are also analyzing SNSE, 0 agree with Samantha's Rating of Hold.



This is the rating of the analyst that currently disagrees with Samantha


  • Francois Brisebois of "Oppenheimer" Upgraded from Hold to Buy and Held Target at $5 on, Monday, October 3rd, 2022